image11701529 161 KB He sent it to the company and they gave him a huge credit and did a big apology thing
Researchers who invest in understanding this compound's unique properties will be well-positioned to contribute to advancing metabolic research and therapeutic development
RETATRUTIDE RETATRUTIDE Retatrutide Research Grade Peptide Retatrutide is an investigational amino acid peptide studied as a triple hormone receptor agonist, simultaneously targeting the GLP-1, GIP, and glucagon receptors to evaluate comprehensive metabolic effects in research
The 'microdose' package costs $119 initially, then $199 per month thereafter, and is claimed to "unlock weight loss and long-term health benefits while minimising side effects" through "personalised" dosing
Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist that effectively controls blood glucose and promotes weight loss, but discontinuation often leads to weight regain and glycemic deterioration
Below are the monthly prices for each drug